Biotech Investors & VC Firms in Europe
832 firms in this list, with a median first check of $500K. 187 of them lead rounds. Generated from verified public data and updated continuously.
Pureos Bioventures
PfäffikonSeed–Series C
9 people
3xP Global
LisbonSeries A–Series B$1.1M – $10.8M
5 people
MBG Mittelständische Beteiligungsgesellschaft Hamburg mbH
HamburgSeed–Growth$108K – $540K
14 people
Perivoli Innovations
St. HelierPre-Seed–Growth
2 people
Export and Investment Fund
CopenhagenPre-Seed–Growth$108K – $7.6M
13 people
Artemis Growth Partners
LondonSeed–Series B
1 person
Claris Ventures
TurinPre-Seed–Series A
13 people
Freigeist Capital
BonnSeed–Series A$550K – $2.2M
7 people
Biovance Capital Partners SCR
LisbonSeed–Series A
16 people
Sambrinvest
CharleroiSeries A–Late Stage
13 people
Alta Semper Capital
LondonGrowth$20M – $60M
11 people
2050 Capital
LondonSeed–Series C$200K – $3M
7 people
Agronomics
LondonSeed–Series B
7 people
Granatus Ventures
YerevanSeed–Growth$100K – $4.7M
4 people
Neulogy Ventures
LuxembourgPre-Seed–Growth$216K – $3.2M
4 people
Sound Bioventures
MalmöSeed–Late Stage
9 people
WA4STEAM
BarcelonaPre-Seed–Series A
6 people
Innvotec Ltd.
LondonSeries A–Series B$317.5K – $635K
4 people
Prosperus-invest
ZagrebGrowth$5.4M – $10.8M
7 people
Impact Ventures
BudapestSeed–Series A$378K – $1.6M
6 people
GENIUS Venture Capital
SchwerinPre-Seed–Series A$540K – $1.6M
4 people
AdBio partners
ParisPre-Seed–Series A
3 people
Building Global Innovators
LisbonPre-Seed–Seed
15 people
Form Ventures
LondonPre-Seed–Series A$254K – $1.3M
3 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Healthtech Investors & VC Firms (3408)
Data sourced from public filings and firms' own websites — see our methodology.




























































































